Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: Correlation of genotypic methods with viral phenotype and clinical outcome

Douglas Jabs, Barbara K. Martin, Michelle O. Ricks, Michael S. Forman

Research output: Contribution to journalArticle

Abstract

Background. The cytomegalovirus (CMV) UL97 gene can be sequenced either from blood specimens directly amplified by polymerase chain reaction (PCR) or from culture isolates, to detect resistance to ganciclovir. Methods. A prospective epidemiological study was conducted in which paired specimens were routinely obtained for sequencing of the UL97 gene from blood specimens (i.e., plasma and leukocytes) directly amplified by PCR and from CMV culture isolates. The specimens then were compared with each other and in terms of results of susceptibility testing and their association with progression of retinitis. Results. A total of 845 paired specimens were obtained from 165 patients with AIDS and CMV retinitis. There typically was >90% agreement between the UL97 gene sequences from blood specimens directly amplified by PCR and those from culture isolates. The agreement between phenotypic resistance and the detection of UL97 mutations was >92% for PCR-amplified blood specimens and >97% for culture isolates. Plasma and leukocytes performed similarly. Progression of retinitis was correlated with the detection of UL97 mutations in PCR-amplified blood specimens, with adjusted odds ratios of 7.02 (P = .002) for leukocytes, 9.11 (P = .02) for plasma, and 17.6 for culture isolates (P<.0001). Conclusions. Because blood specimens directly amplified by PCR can be analyzed more rapidly than can cultures (≤48 h vs. ≥4 weeks), sequencing the CMV UL97 gene from blood specimens directly amplified by PCR may be useful clinically.

Original languageEnglish (US)
Pages (from-to)1728-1737
Number of pages10
JournalJournal of Infectious Diseases
Volume193
Issue number12
DOIs
StatePublished - Jun 15 2006

Fingerprint

Cytomegalovirus Retinitis
Ganciclovir
Acquired Immunodeficiency Syndrome
Phenotype
Polymerase Chain Reaction
Cytomegalovirus
Retinitis
Leukocytes
Genes
Mutation
Epidemiologic Studies
Odds Ratio
Prospective Studies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis : Correlation of genotypic methods with viral phenotype and clinical outcome. / Jabs, Douglas; Martin, Barbara K.; Ricks, Michelle O.; Forman, Michael S.

In: Journal of Infectious Diseases, Vol. 193, No. 12, 15.06.2006, p. 1728-1737.

Research output: Contribution to journalArticle

@article{60cb2e71523a4a19bd622a443ede3d22,
title = "Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: Correlation of genotypic methods with viral phenotype and clinical outcome",
abstract = "Background. The cytomegalovirus (CMV) UL97 gene can be sequenced either from blood specimens directly amplified by polymerase chain reaction (PCR) or from culture isolates, to detect resistance to ganciclovir. Methods. A prospective epidemiological study was conducted in which paired specimens were routinely obtained for sequencing of the UL97 gene from blood specimens (i.e., plasma and leukocytes) directly amplified by PCR and from CMV culture isolates. The specimens then were compared with each other and in terms of results of susceptibility testing and their association with progression of retinitis. Results. A total of 845 paired specimens were obtained from 165 patients with AIDS and CMV retinitis. There typically was >90{\%} agreement between the UL97 gene sequences from blood specimens directly amplified by PCR and those from culture isolates. The agreement between phenotypic resistance and the detection of UL97 mutations was >92{\%} for PCR-amplified blood specimens and >97{\%} for culture isolates. Plasma and leukocytes performed similarly. Progression of retinitis was correlated with the detection of UL97 mutations in PCR-amplified blood specimens, with adjusted odds ratios of 7.02 (P = .002) for leukocytes, 9.11 (P = .02) for plasma, and 17.6 for culture isolates (P<.0001). Conclusions. Because blood specimens directly amplified by PCR can be analyzed more rapidly than can cultures (≤48 h vs. ≥4 weeks), sequencing the CMV UL97 gene from blood specimens directly amplified by PCR may be useful clinically.",
author = "Douglas Jabs and Martin, {Barbara K.} and Ricks, {Michelle O.} and Forman, {Michael S.}",
year = "2006",
month = "6",
day = "15",
doi = "10.1086/504270",
language = "English (US)",
volume = "193",
pages = "1728--1737",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis

T2 - Correlation of genotypic methods with viral phenotype and clinical outcome

AU - Jabs, Douglas

AU - Martin, Barbara K.

AU - Ricks, Michelle O.

AU - Forman, Michael S.

PY - 2006/6/15

Y1 - 2006/6/15

N2 - Background. The cytomegalovirus (CMV) UL97 gene can be sequenced either from blood specimens directly amplified by polymerase chain reaction (PCR) or from culture isolates, to detect resistance to ganciclovir. Methods. A prospective epidemiological study was conducted in which paired specimens were routinely obtained for sequencing of the UL97 gene from blood specimens (i.e., plasma and leukocytes) directly amplified by PCR and from CMV culture isolates. The specimens then were compared with each other and in terms of results of susceptibility testing and their association with progression of retinitis. Results. A total of 845 paired specimens were obtained from 165 patients with AIDS and CMV retinitis. There typically was >90% agreement between the UL97 gene sequences from blood specimens directly amplified by PCR and those from culture isolates. The agreement between phenotypic resistance and the detection of UL97 mutations was >92% for PCR-amplified blood specimens and >97% for culture isolates. Plasma and leukocytes performed similarly. Progression of retinitis was correlated with the detection of UL97 mutations in PCR-amplified blood specimens, with adjusted odds ratios of 7.02 (P = .002) for leukocytes, 9.11 (P = .02) for plasma, and 17.6 for culture isolates (P<.0001). Conclusions. Because blood specimens directly amplified by PCR can be analyzed more rapidly than can cultures (≤48 h vs. ≥4 weeks), sequencing the CMV UL97 gene from blood specimens directly amplified by PCR may be useful clinically.

AB - Background. The cytomegalovirus (CMV) UL97 gene can be sequenced either from blood specimens directly amplified by polymerase chain reaction (PCR) or from culture isolates, to detect resistance to ganciclovir. Methods. A prospective epidemiological study was conducted in which paired specimens were routinely obtained for sequencing of the UL97 gene from blood specimens (i.e., plasma and leukocytes) directly amplified by PCR and from CMV culture isolates. The specimens then were compared with each other and in terms of results of susceptibility testing and their association with progression of retinitis. Results. A total of 845 paired specimens were obtained from 165 patients with AIDS and CMV retinitis. There typically was >90% agreement between the UL97 gene sequences from blood specimens directly amplified by PCR and those from culture isolates. The agreement between phenotypic resistance and the detection of UL97 mutations was >92% for PCR-amplified blood specimens and >97% for culture isolates. Plasma and leukocytes performed similarly. Progression of retinitis was correlated with the detection of UL97 mutations in PCR-amplified blood specimens, with adjusted odds ratios of 7.02 (P = .002) for leukocytes, 9.11 (P = .02) for plasma, and 17.6 for culture isolates (P<.0001). Conclusions. Because blood specimens directly amplified by PCR can be analyzed more rapidly than can cultures (≤48 h vs. ≥4 weeks), sequencing the CMV UL97 gene from blood specimens directly amplified by PCR may be useful clinically.

UR - http://www.scopus.com/inward/record.url?scp=33744799393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744799393&partnerID=8YFLogxK

U2 - 10.1086/504270

DO - 10.1086/504270

M3 - Article

C2 - 16703517

AN - SCOPUS:33744799393

VL - 193

SP - 1728

EP - 1737

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 12

ER -